Eplerenone in the management of resistant hypertension with obstructive sleep apnoea in pregnancy

Pregnancy Hypertens. 2017 Jan:7:54-55. doi: 10.1016/j.preghy.2016.12.001. Epub 2016 Dec 20.

Authors

Adam Morton¹, Josephine Laurie²

Affiliations

¹ University of QLD, Raymond Terrace, South Brisbane, QLD 4101, Australia; Mater Health, Raymond Terrace, South Brisbane, QLD 4101, Australia. Electronic address: Adam.Morton@mater.org.au.
² University of QLD, Raymond Terrace, South Brisbane, QLD 4101, Australia; Mater Health, Raymond Terrace, South Brisbane, QLD 4101, Australia. Electronic address: Josephine.Laurie@mater.org.au.

PMID: 28279449
DOI: 10.1016/j.preghy.2016.12.001

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Eplerenone
Female
Humans
Mineralocorticoid Receptor Antagonists / adverse effects
Mineralocorticoid Receptor Antagonists / therapeutic use*
Obesity, Morbid / complications*
Pre-Eclampsia / drug therapy*
Pregnancy
Pregnancy Outcome
Sleep Apnea, Obstructive / complications
Spironolactone / adverse effects
Spironolactone / analogs & derivatives*
Spironolactone / therapeutic use
Ultrasonography, Prenatal

Substances

Mineralocorticoid Receptor Antagonists
Spironolactone
Eplerenone